Abstract

Atherosclerosis is a common metabolic disease characterized by lipid metabolic disorder. The processes of atherosclerosis include endothelial dysfunction, new endothelial layer formation, lipid sediment, foam cell formation, plaque formation, and plaque burst. Owing to the adverse effects of first-line medications, it is urgent to discover new medications to deal with atherosclerosis. Berberine is one of the most promising natural products derived from traditional Chinese medicine. However, the panoramic mechanism of berberine against atherosclerosis has not been discovered clearly. In this study, we used network pharmacology to investigate the interaction between berberine and atherosclerosis. We identified potential targets related to berberine and atherosclerosis from several databases. A total of 31 and 331 putative targets for berberine and atherosclerosis were identified, respectively. Then, we constructed berberine and atherosclerosis targets with PPI data. Berberine targets network with PPI data had 3204 nodes and 79437 edges. Atherosclerosis targets network with PPI data had 5451 nodes and 130891 edges. Furthermore, we merged the two PPI networks and obtained the core PPI network from the merged PPI network. The core PPI network had 132 nodes and 3339 edges. At last, we performed functional enrichment analyses including GO and KEGG pathway analysis in David database. GO analysis indicated that the biological processes were correlated with G1/S transition of mitotic cells cycle. KEGG pathway analysis found that the pathways directly associated with berberine against atherosclerosis were cell cycle, ubiquitin mediated proteolysis, MAPK signaling pathway, and PI3K-Akt signaling pathway. After combining the results in context with the available treatments for atherosclerosis, we considered that berberine inhibited inflammation and cell proliferation in the treatment of atherosclerosis. Our study provided a valid theoretical foundation for future research.

Highlights

  • Atherosclerosis is a common chronic disorder that plaque builds up in the arteries [1]

  • We performed the functional enrichment analyses including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway analysis to characterize the biological processes and pathways. e results of this study provided a comprehensive and meaningful analysis of berberine in treating atherosclerosis. is study provided a novel mechanism of berberine against atherosclerosis

  • A total of 331 putative targets of atherosclerosis were identified with Target Database (TTD), DrugBank, Genetic Association Database (GAD), Online Mendelian Inheritance in Man (OMIM) databases. e putative targets included ABCA1, ANKRD1, CNR2, ICAM1, and so on. e detailed information about the potential targets of atherosclerosis was listed in Figure 3 and Supplementary Table 2

Read more

Summary

Introduction

Atherosclerosis is a common chronic disorder that plaque builds up in the arteries [1]. Calcium, fat, and other substances in the bloodstream [2]. High blood pressure, smoking, abnormal cholesterol levels, and obesity are considered as risk factors of atherosclerosis. Previous studies have demonstrated that several cardiovascular and cerebrovascular diseases such as coronary artery disease, cerebral infarction, cerebral hemorrhage were correlated with atherosclerosis [3, 4]. Atherosclerosis is one of the most important factors leading to disability and death. Increased production of proinflammatory mediators including interferons (IFNs), interleukins (ILs), transforming growth factors (TGFs), and tumor necrosis factors (TNFs) take part in the initiation and development of atherosclerosis [8]. E available treatments of atherosclerosis include statins, surgery, and other medications. Erefore, it is urgent to discover new medications to deal with atherosclerosis Evidence-Based Complementary and Alternative Medicine there are many side effects of these methods [9]. erefore, it is urgent to discover new medications to deal with atherosclerosis

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call